Composite end points: implications of changing compositions with longer follow-up

The use of composite end points (CEP) in clinical trials and observational studies is widespread, despite continuing controversies on methodological and interpretational aspects.1 It is commonly recommended to construct CEP only from component outcomes that represent different manifestations of simi...

Full description

Saved in:
Bibliographic Details
Main Authors: Breitling, Lutz Philipp (Author) , Mons, Ute (Author) , Brenner, Hermann (Author)
Format: Article (Journal)
Language:English
Published: August 30, 2017
In: Circulation. Cardiovascular quality and outcomes
Year: 2017, Volume: 10, Issue: 9
ISSN:1941-7705
DOI:10.1161/CIRCOUTCOMES.116.003458
Online Access:Verlag, teilw. kostenfrei, Volltext: http://dx.doi.org/10.1161/CIRCOUTCOMES.116.003458
Verlag, teilw. kostenfrei, Volltext: http://circoutcomes.ahajournals.org/content/10/9/e003458
Get full text
Author Notes:Lutz P. Breitling, Ute Mons, Harry Hahmann, Wolfgang Koenig, Dietrich Rothenbacher, Hermann Brenner

MARC

LEADER 00000caa a22000002c 4500
001 1564097595
003 DE-627
005 20230427142047.0
007 cr uuu---uuuuu
008 171005s2017 xx |||||o 00| ||eng c
024 7 |a 10.1161/CIRCOUTCOMES.116.003458  |2 doi 
035 |a (DE-627)1564097595 
035 |a (DE-576)494097590 
035 |a (DE-599)BSZ494097590 
035 |a (OCoLC)1340980003 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Breitling, Lutz Philipp  |d 1978-  |e VerfasserIn  |0 (DE-588)132680890  |0 (DE-627)525179690  |0 (DE-576)259782394  |4 aut 
245 1 0 |a Composite end points  |b implications of changing compositions with longer follow-up  |c Lutz P. Breitling, Ute Mons, Harry Hahmann, Wolfgang Koenig, Dietrich Rothenbacher, Hermann Brenner 
264 1 |c August 30, 2017 
300 |a ? 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.10.2017 
520 |a The use of composite end points (CEP) in clinical trials and observational studies is widespread, despite continuing controversies on methodological and interpretational aspects.1 It is commonly recommended to construct CEP only from component outcomes that represent different manifestations of similar pathophysiologic processes, are of similar patient importance, similar frequency, and with similar associations with the predictor/intervention. 2 In the cardiovascular field, where more than one third of trials use some kind of CEP, it has been shown that the effect estimates based on CEP are mostly driven by more frequent but less severe component outcomes. 3 Fatal component outcomes in clinical trials, on the other hand, tend to occur with the lowest frequency and often feature the weakest treatment effects. 4. The possibly complicating role of study duration and follow-up time has attracted hardly any attention in this context. It has been suggested, for example, that long-term studies on valve implantation need to consider time-related component outcomes, such as valve failure.5 However, more generally, the contribution of fatal component outcomes may be expected to increase with substantial long-term follow-up, especially in chronic disease studies in the elderly. Fundamental to both examples—valve failure and higher age mortality—is the understanding that the relative composition of the CEP may change with increasing study duration. This could lead to study duration-dependent changes of the association of a risk factor with the CEP, not because of time-varying effects of the risk factor on the component outcomes, but because of a time-varying composition of the CEP. Because the relevance of such study duration-dependent CEP compositions has not been investigated to date, the aim of the present work is to empirically address this issue in a cardiovascular patient cohort followed during 13 years. The present work is based on the observational KAROLA prospective cohort study … 
700 1 |a Mons, Ute  |d 1981-  |e VerfasserIn  |0 (DE-588)13684992X  |0 (DE-627)587812753  |0 (DE-576)301308829  |4 aut 
700 1 |a Brenner, Hermann  |e VerfasserIn  |0 (DE-588)1020516445  |0 (DE-627)691247005  |0 (DE-576)360642136  |4 aut 
773 0 8 |i Enthalten in  |t Circulation. Cardiovascular quality and outcomes  |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 2008  |g 10(2017,9), Artikel-Nummer e003458, ? Seiten  |w (DE-627)579833887  |w (DE-600)2453882-6  |w (DE-576)337573468  |x 1941-7705  |7 nnas  |a Composite end points implications of changing compositions with longer follow-up 
773 1 8 |g volume:10  |g year:2017  |g number:9  |g extent:?  |a Composite end points implications of changing compositions with longer follow-up 
856 4 0 |u http://dx.doi.org/10.1161/CIRCOUTCOMES.116.003458  |x Verlag  |x Resolving-System  |z teilw. kostenfrei  |3 Volltext 
856 4 0 |u http://circoutcomes.ahajournals.org/content/10/9/e003458  |x Verlag  |z teilw. kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20171005 
993 |a Article 
994 |a 2017 
998 |g 1020516445  |a Brenner, Hermann  |m 1020516445:Brenner, Hermann  |d 850000  |d 851600  |e 850000PB1020516445  |e 851600PB1020516445  |k 0/850000/  |k 1/850000/851600/  |p 6  |y j 
998 |g 13684992X  |a Mons, Ute  |m 13684992X:Mons, Ute  |d 50000  |e 50000PM13684992X  |k 0/50000/  |p 2 
998 |g 132680890  |a Breitling, Lutz Philipp  |m 132680890:Breitling, Lutz Philipp  |d 50000  |e 50000PB132680890  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1564097595  |e 2982759268 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Lutz P. Breitling, Ute Mons, Harry Hahmann, Wolfgang Koenig, Dietrich Rothenbacher, Hermann Brenner"]},"note":["Gesehen am 05.10.2017"],"recId":"1564097595","language":["eng"],"id":{"eki":["1564097595"],"doi":["10.1161/CIRCOUTCOMES.116.003458"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"August 30, 2017","dateIssuedKey":"2017"}],"title":[{"subtitle":"implications of changing compositions with longer follow-up","title":"Composite end points","title_sort":"Composite end points"}],"person":[{"family":"Breitling","display":"Breitling, Lutz Philipp","given":"Lutz Philipp","role":"aut"},{"given":"Ute","display":"Mons, Ute","family":"Mons","role":"aut"},{"role":"aut","given":"Hermann","display":"Brenner, Hermann","family":"Brenner"}],"physDesc":[{"extent":"? S."}],"relHost":[{"part":{"text":"10(2017,9), Artikel-Nummer e003458, ? Seiten","issue":"9","volume":"10","extent":"?","year":"2017"},"title":[{"partname":"Cardiovascular quality and outcomes","subtitle":"journal of the American Heart Association","title":"Circulation","title_sort":"Circulation"}],"titleAlt":[{"title":"Circulation / Cardiovascular quality and outcomes"}],"origin":[{"dateIssuedDisp":"2008-","publisherPlace":"Philadelphia, Pa.","publisher":"Lippincott, Williams & Wilkins","dateIssuedKey":"2008"}],"corporate":[{"role":"isb","display":"American Heart Association"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["579833887"],"zdb":["2453882-6"],"issn":["1941-7705"]},"language":["eng"],"recId":"579833887","pubHistory":["1.2008 -"],"disp":"Composite end points implications of changing compositions with longer follow-upCirculation. Cardiovascular quality and outcomes"}]} 
SRT |a BREITLINGLCOMPOSITEE3020